Nurse Practitioner · Palm Springs, CA
NPI
1598224024
Since 2019
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1111 E Tahquitz Canyon Way Ste 120
Palm Springs, CA, 92262
Phone (760) 837-8366
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
10,675 services
Medicare patients, 2024
251
Average age 70
Drug cost, 2024
$4.2M
6,207 prescriptions
Company payments, 2025
$132
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cristian E Villegas was code J1071 (injection, testosterone cypionate, 1 mg), 10,000 times for 12 patients. In total Cristian E Villegas billed 10,675 services in 19 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 10,000 | 12 | $0.02 | $170 |
| 99214 Office E&M - Established | Office | 427 | 198 | $79.86 | $34K |
| 99213 Office E&M - Established | Office | 101 | 84 | $59.40 | $5,999 |
| 96372 Injection Administration | Office | 59 | 17 | $9.38 | $554 |
By year: 2022 $41K for 4,253 services; 2023 $46K for 6,123 services; 2024 $46K for 10,675 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 16 | 15 | $2.22 | $35.59 |
Medicare prescription drug claims, 2024
In 2024, the drug Cristian E Villegas prescribed most often to Medicare patients was Descovy (Emtricitabine/Tenofov Alafenam), with 342 prescriptions and refills. In total Cristian E Villegas wrote 6,207 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Descovy Emtricitabine/Tenofov Alafenam | 342 | 370 | 54 | $837K |
| Atorvastatin Calcium Generic | 273 | 788 | 93 | $2,572 |
| Doxycycline Hyclate Generic | 217 | 225 | 86 | $1,646 |
| Testosterone Cypionate Generic | 207 | 326 | 59 | $9,511 |
| Losartan Potassium Generic | 193 | 475 | 54 | $1,828 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 189 | 211 | 27 | $822K |
| Trazodone Hcl Generic | 180 | 332 | 46 | $1,677 |
| Tivicay Dolutegravir Sodium | 178 | 195 | 25 | $447K |
| Lisinopril Generic | 152 | 350 | 37 | $1,003 |
| Omeprazole Generic | 148 | 321 | 36 | $1,543 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 147 | 356 | 42 | $3,607 |
| Anastrozole Generic | 134 | 328 | 43 | $915 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 133 | 165 | 21 | $679K |
| Rosuvastatin Calcium Generic | 133 | 337 | 39 | $2,499 |
| Tamsulosin Hcl Generic | 106 | 226 | 31 | $1,251 |
Brand drugs: 1,552 claims; generic drugs: 4,624 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cristian E Villegas $132 ($132 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $132.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.